Tennessee Oncology, a nationally recognized independent oncology practice with 35 clinics across Tennessee and Northwest Georgia, announced today new roles for three physician executive leaders.
Johnetta Blakely, MD, MS, MMHC; Casey Chollet Lipscomb, MD, and Edward R. "Ted" Arrowsmith, MD, MPH, have been promoted to Executive Vice President of Quality and Clinical Operations, Physician Services, and Therapeutics,
respectively. All 3 physicians are currently on Tennessee Oncology’s board of directors and are practicing physicians. Blakely practices in Cookeville, Chollet Lipscomb practices in Nashville, and Arrowsmith treats patients in Chattanooga.
“Each of these oncologists are world-class physicians and leaders who will help take Tennessee Oncology to the next level,” said Natalie Dickson, MD, president and chief strategy officer. “I am excited to work alongside my colleagues to build on Tennessee Oncology’s proud history and continue bringing the highest quality of cancer care and innovative therapies to Tennessee patients. Caring for cancer patients is indeed a privilege, and I’m looking forward to contributions of each of my colleagues.”
Blakely attended the University of Tennessee’s medical school. She completed her fellowship in hematology/oncology at MD Anderson Cancer Center, holds a master’s degree in clinical research from MD Anderson as well as a master’s degree in healthcare management from Vanderbilt. Chollet Lipscomb attended medical school at University of Tennessee, conducted her residency at Loyola University Medical Center in Chicago, and was an attending at Duke University prior to joining Tennessee Oncology. Arrowsmith’s medical degree and fellowship are both from Vanderbilt University. He is also the head of pathway development at OneOncology, the fastest growing national platform for independent oncology practices.
T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need
April 30th 2024"Off the shelf" CAR T-cell therapies could offer a solution in chronic lymphocytic leukemia, where T-cell exhaustion creates treatment challenges. This article will appear in the May 2024 issue of Evidence-Based Oncology.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More